The silencing of TSHR not only contributes to the development of thyroid carcinoma, but it desensitizes the thyroid tumors to radioiodine therapy through its interaction with sodium iodide symporter (NIS) in iodide uptake. The gene discussed is TSHR; the disease is thyroid gland carcinoma.